2023 Report details for project: Replacement Analytical Project
| Project name | Replacement Analytical Project - there are 3 reports for this project: 2021, 2022, 2023 |
|---|---|
| Google search | Google search on project name (opens in new window)  |
| Contracts | Contracts search (opens in new window) - under development |
| Organisation | DESNZ (DX01) - see all reports for this organisation |
| Report year | 2023 (data is from September 2022) |
| Category | Infrastructure - see all reports for this category |
| Description: | The Replacement Analytical Project is a key component of the Analytical Services Programme, which provides essential services to operations on the Sellafield Site supporting multiple Programmes & Operational Facilities. The existing facility is 60 years old and cannot provide long-term capability so new analytical facilities need to be established. The Replacement Analytical Project has therefore been initiated to deliver future analytical capability to the Sellafield site, through a major modification of the National Nuclear Laboratory Central Laboratory. Key modifications are provision of standalone Highly Active (HA), Medium Active (MA) and Special Nuclear Material (SNM) analytical capability. A key part of the scope is the delivery of 135 Analytical Instruments which will perform the ongoing analysis required by facilities at Sellafield. Analytical Services remains essential to the delivery of high hazard reduction and remediation until the completion of the Sellafield Ltd mission. |
| DCA (RAG) | Red |
| DCA text: | Compared to financial year 21/22-Q4, the IPA's DCA rating at 22/23-Q4 remained at Red. This is primarily due to the following factors.The red IPA RAG rating was based upon the inability of the project to fall within the OBC cost and schedule range, and that the current range is assessed at a most likely outturn of 1,100-1,300m when compared to the OBC P50 of 680m. The Project will return to the DESNZ Projects and Investment Committee in FY2023/24-Q1 to agree a way ahead. |
| Start date | 2016-09-26 |
| End date | 2028-07-10 |
| Schedule text | Compared to financial year 21/22-Q4, the project's end-date at 22/23-Q4 remained schedule to finish on 2028-07-10. This is primarily due to the following factors.Compared to financial year 21/22-Q4, the project's end-date at 22/23-Q4 remained schedule to finish on 2028-07-10. This is primarily due to the following factors. The baseline end date remains at 10th July 2028. However, the current reported forecast of 9th Nov 2028 for completion of project support to active commissioning reflects a 4 month slippage from the Outline Business Case and baseline date, with the significant factor being the impact of COVID. Given the early maturity of the project in the detailed design phase and typically for projects at this stage, the lifetime schedule for future phases is not underpinned and is likely to change as the project matures. Latest level 3 schedule output states completion dates of September 2031 for Special Nuclear Materials (SNM) and October 2032 for Medium Active / Highly Active (MA/HA), these dates will be reflected in the forecast for the quarter 1 submission. |
| Baseline | £85.93m |
| Forecast | £54.78m |
| Variance | -36.00% |
| Variance text: | The in year baseline of 85.93m represents the planned scope to be delivered against the plan put in place in 2019. Actual scope being delivered this financial year is 16.07m, at a cost of 54.78m. The project has delivered less scope than originally planned due to delays in completing design and progressing enabling works (COVID-19 / resourcing issues / supply chain contract delays). The actual scope that has been delivered has cost more than planned due to the requirement of additional design hours and increased management and overhead costs. |
| Whole Life Cost | £712.00m |
| WLCost text: | Compared to financial year 21/22-Q4, the project's departmental-agree Whole Life Cost at 22/23-Q4 increased from 648m. to 712m. This is primarily due to the following factors.Compared to financial year 21/22-Q4, the project's departmental-agree Whole Life Cost at 22/23-Q4 increased from 648m. to 712m. This is primarily due to the following factors. Compared to 21/22-Q4, the RAP budgeted cost (baseline) has increased by 63.93m, this is due to escalation in line with the agreed indices. |
| Notes1: | |
| Notes2: | |
| Sourcefile | IPA_2023.csv |
Home Selection Search All Reports Projects +dates Projects +costs Organisations Years Categories
Acknowledgement: GMPP data has been re-used under the Open Government Licence.